Tải xuống
Tóm tắt
ABSTRACT
Purpose: We investigated the influence of baseline characteristics of patients with hepatocellular carcinoma (HCC) on prognosis.
Methods: A Retrospective descriptive study on patients with HCC was carry out at the Oncology Department of Hue University of Medicine and Pharmacy Hospital and Hue Central Hospital (HCH), Viet Nam, from Oct 2015 to Dec 2019. Demographic, laboratory, tumor characteristics, and performance status were determined before treatment. Predictors of survival were identified using the Kaplan - Meir test and the Cox model.
Result: A total of 261 patients, 87.4% male; median age was 58.4; 80,1% of patients admitted to hospital because of right upper quadrant pain. 45.2% ECOG 0, 51.7% ECOG 1; AFP > 400 ng/mlhas 67.4%. The most robust predictors of survival were tumor size, ECOG, portal vein tumor thrombus, Barcelona Clinic Liver Cancer (BCLC), initial treatment. Overall survival in patients with HCC was 9.0 months. In a multivariate analysis: BCLC and initial treatment modalities were independent predictors of survival.
Conclusions - Patients with HCC had a poor survival with a median of nine months. Five easily measurable clinical variables were significant predictors of survival in patients with HCC.
Tài liệu tham khảo
Trần Tiến Duy, Mô tả đặc điểm lâm sàng, cận lâm sàng của bệnh nhân ung thư biểu mô tế bào gan. Báo cáo nghiên cứu khoa học cấp cơ sở,
bệnh viện đa khoa tỉnh Ninh Thuận. Tháng 9 năm 2018.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 2018; 68 (6): 394-424.
Rawla P, Sunkara T, Muralidharan P, et al. Update in global trends and etiology of hepatocellular carcinoma, Contemp Oncol (Pozn). 2018;
(3):141-150.
Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma, Lancet, 2012;379(9822):1245-1255.
Daher S, Massarwa M., Benson A. A, et al. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review, J Clin Transl Hepatol, 2018;6(1):69-78.
Farinati F, Vitale A, Spolverato G, et al. Development and Validation of a New Prognostic System for Patients with Hepatocellular
Carcinoma. PLoS Med. 2016;13(4):e1002006.
Abdelaziz A, Shousha H, Abdelmaksoud A. h. K, et al. A new prognostic score can predict survival after hepatocellular carcinoma treatment
in a cohort of 1302 Egyptian hepatocellular carcinoma patients, European Journal of Gastroenterology & Hepatology, 2018;30:1.
Piñero F, Dirchwolf M, Pessôa M.G. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment,
Cells, 2020;9(6):1370.
Wang C, Li S. Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma, Medicine (Baltimore), 2019; 98(4): e14070.
| Đã xuất bản | 24-01-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 72 (2021) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.38103/jcmhch.2021.72.9 | |
| Từ khóa | Keywords: Hepatocellular carcinoma; clinical presentation; prognostic model. |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2021 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế